|Event:||28th Annual Piper Jaffray Healthcare Conference|
|Format:||Presentation and One-on-One Meetings|
|Date:||Wednesday, November 30th, 2016|
|Time:||3:20 pm ET|
PLANO, Texas, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Financial Officer, are scheduled to present at the 28 th Annual Piper Jaffray Healthcare Conference in New York, NY. Management will also be available for one-on-one meetings at the conference.
A webcast of the Company's presentation will be available by visiting the investor relations section of Nuvectra's website at www.nuvectramed.com. A webcast replay of the presentation will be available for 90 days. About Nuvectra Corporation Nuvectra™ is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.